Halozyme slips as German court overturns injunction against Merck
FROM THE WIRE · SEEKINGALPHA.COM
Halozyme (HALO) stock fell after a German court overturned an injunction blocking Merck's (MRK) injectable Keytruda. Read more here.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishOverturning the injunction affects a key Merck product and weighs on Halozyme shares.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01A German court overturned an injunction blocking Merck's injectable Keytruda.
- 02Halozyme (HALO) stock fell following the decision.
- 03Merck (MRK) is affected by the reversal of the injunction.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Halozyme Therapeutics, Inc.91.71 USD-1.97%today -4.27%Negative Merck & Co., Inc.133.53 USD-0.89%today -3.08%Neutral
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets